Skip to main content
Log in

Gender-related differences in proliferative response of cardiac fibroblasts to hypoxia

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Ischemic heart disease is more prevalent in men than in women. The remodeling of extracellular matrix, is a structural correlate of heart failure of ischemic origin and proliferation of cardiac fibroblasts is a key factor in this remodeling. We asked if proliferative response of male and female cardiac fibroblasts is differentially susceptible to hypoxia. DNA synthesis, using 3H-thymidine incorporation was compared under hypoxia (2% O2) in cardiac fibroblasts obtained from adult, age-matched male and female rat heart. In female cells DNA synthesis remained unchanged under hypoxia and this resistance was dependent on tyrosine kinase activation, as it was abolished in the presence of genistein, a tyrosine kinase inhibitor. Male cells, on the other hand, were susceptible to hypoxia and their DNA synthesis was reduced significantly (70%, (p < 0.0001). This effect was partially reversed by inhibition of tyrosine kinase. Western analysis showed a higher abundance of tyrosine phosphorylated proteins in male cells compared to female cells as well as differences in molecular weight of basal and hypoxia-induced tyrosine-phosphorylated proteins between male and female cells. The presence of estrogen (17-β estradiol, 10 nM) altered the response of both cells to hypoxia. In female cells the combined effect of hypoxia and estrogen led to inhibition of DNA synthesis, whereas in male cells estrogen partially reversed the hypoxia-induced inhibition of DNA synthesis (37% (p < 0.01) inhibition in the presence of estrogen vs. 70% (p < 0.0001) inhibition in the absence of estrogen). The effects of estrogen in male and female cells were mediated via estrogen receptors as they were reversed by the pure anti-estrogen, ICI 182,780. Western analysis of cell lysate showed hypoxia-induced increase in the level of estrogen receptor β in both male and female cells. Gel shift analysis showed hypoxia-induced increase in cytoplasmic ERE (estrogen response element)-binding activity and decrease in nuclear ERE-binding in male cells. In female cells cytoplasmic and nuclear ERE-binding activities remained unchanged under hypoxia. Together, these data demonstrate that while female cells are resistant to hypoxia-induced inhibition in DNA synthesis, male cells are susceptible; intracellular pathways involving tyrosine phosphorylation are involved in the response of both cells; and estrogen, via estrogen-receptor-dependent mechanisms, differentially alters the response of male and female cells to hypoxia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Conner E: Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association. Circulation 96: 2468–2482, 1997

    Google Scholar 

  2. Isles CG, Hole DJ, Hawthorne VM, Lever AF: Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: Comparison with men. Lancet 339: 702–706, 1992

    Google Scholar 

  3. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E: Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 260: H1406–H1414, 1991

    Google Scholar 

  4. Volders PG, Willems IE, Cleutjens JP: Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol 25: 1317–1323, 1993

    Google Scholar 

  5. Whittaker P, Boughner DR, Kloner RA: Role of collagen in acute myocardial infarct expansion. Circulation 84: 2123–2134, 1991

    Google Scholar 

  6. Schaper J: Effect of multiple ischemic events on human myocardium: An ultrastructural study. Eur Heart J 9: 141–149, 1998

    Google Scholar 

  7. Mandes LA, Davidoff R, Cupples LA, Ryan TJ, Jacobs AK: Congestive heart failure in patients with coronary artery disease: The gender paradox. Am Heart J 134: 207–212, 1997

    Google Scholar 

  8. Ho KKL, Anderson KM, Kannel WB, Grossmann W, Levy D: Survival after the onset of congestive heart failure in the Framingham Heart Study subjects. Circulation 88: 107–115, 1993

    Google Scholar 

  9. Gardin JM, Wagenknecht LE, Anton-Culver ?, Flack J, Gidding S, Jurosaki T, Wong ND, Manolio TA: Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white men and women. Circulation 92: 380–387, 1995

    Google Scholar 

  10. Kuizinga MC, Smits JFM, Arends JW, Daemen MJAP: AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. J Mol Cell Cardiol 30: 425–434, 1998

    Google Scholar 

  11. Agocha A, Eghbali-Webb M: Hypoxia regulates DNA synthesis and collagen type I production in human cardiac fibroblasts: Effects of transforming growth factor-β1, thyroid hormone, angiotensin II and basic fibroblast growth factor. J Mol Cell Cardiol 29: 2233–2244, 1997

    Google Scholar 

  12. Lee H-W, Eghbali-Webb M: Estrogen enhances proliferation of cardiac fibroblasts via mitogen-activated protein kinase-and estrogen receptor-dependent pathways. J Mol Cell Cardiol 30: 1359–1368, 1998

    Google Scholar 

  13. Sadoshima J, Jahn L, Takahashi T, Kulik TJ, Izumo S: Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vivo model of load-induced cardiac hypertrophy. J Biol Chem 267: 10551–10560, 1992

    Google Scholar 

  14. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM: Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72: 1245–1254, 1993

    Google Scholar 

  15. Sigel AV, Centrella M, Eghbali-Webb M: Regulation of proliferative response of cardiac fibroblasts by transforming growth factor-β1. J Mol Cell Cardiol 28: 1921–1929, 1996

    Google Scholar 

  16. Simm A, Nestler M, Hoppe V: PDGF-AA, a potent mitogen for cardiac fibroblasts from adult rats. J Mol Cell Cardiol 29: 357–368, 1997

    Google Scholar 

  17. Kacimi R, Karliner JS, Koudssi F, Long CS: Expression and regulation of adhesion molecules in cardiac cells by cytokines: Response to acute hypoxia. Circ Res 23: 576–586, 1998

    Google Scholar 

  18. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 328: 1069–1075, 1993

    Google Scholar 

  19. Dubey RK, Gillespie DG, Jackson EK, Keller PJ: 17Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension 31: 522–528, 1998

    Google Scholar 

  20. Grohe C, Kahlert S, Lobbert K, Van Eickels M, Stimpel M, Vetter H, Neyses L: Effects of moexiprilat on oestrogen-stimulated cardiac fibroblast growth. Br J Pharmacol 121: 1350–1354, 1997

    Google Scholar 

  21. Grohe C, Kahlert S, Lobbert K, Vetter H: Expression of estrogen receptor alpha and beta in rat heart: Role of local estrogen synthesis. J Endocrinol 156: R1–R7, 1998

    Google Scholar 

  22. Eghbali M, Tomek R, Sukhatme V, Woods C, Bhambi B: Differential effects of transforming growth factor-β1 and phorbol mirystate acetate on cardiac fibroblasts: Regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ Res 69: 483–490, 1991

    Google Scholar 

  23. Eghbali M: Cellular origin and distribution of transforming growth factor-β1 in the normal rat myocardium. Cell Tiss Res 256: 553–558, 1989

    Google Scholar 

  24. Migliaccio A, Di Domenico M, Castoria G, De Falco A, Bontempo P, Nola E, Auricchio F: Tyrosine kinase/p21ras/Map-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15: 1292–1300, 1996

    Google Scholar 

  25. Wakeling AE, Bowler J: Novel antiestrogens without partial agonist activity. J Steroid Biochem 31: 645–653, 1988

    Google Scholar 

  26. Akiyama T, Nakagawa S, Ogawara H, Watanabe S, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592–5595, 1987

    Google Scholar 

  27. Shapiro DJ, Sharp PA, Wahli WW, Keller M: A high-efficiency Hela cell nuclear transcription extract. DNA 7: 47–55, 1988

    Google Scholar 

  28. Lee H-W, Klein LE, Raser J, Eghbali-Webb M: An activator protein-1 (AP-1) response element on pro α1(l) collagen gene is necessary for thyroid hormone-induced inhibition of promoter activity in cardiac fibroblasts. J Mol Cell Cardiol 30: 2495–2506, 1998

    Google Scholar 

  29. Klein-Hiptass L, Schorpp M, Wagner U, Ryttel GU: An estrogen-responsive element derived from the 5' flanking region of the xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46:1053–1061, 1986

    Google Scholar 

  30. Arnold SF, Vorojeikina DP, Notides AC: Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J Biol Chem 270: 30205–30212, 1995

    Google Scholar 

  31. Kadonaga JT, Tijian R: Affinity purification of sequence-specific DNA-binding proteins. Proc Natl Acad Sci 83: 5889–5893, 1986

    Google Scholar 

  32. Guerra S, Leri A, Wang X, Finaton N, Loretto C, Beltrami CA, Kajstura J, Anversa P: Myocyte death in the failing human heart is gender dependent. Circ Res 85: 856–866, 1999

    Google Scholar 

  33. Collins P, Rosano GMC, Sarrel PM, Ulrich L, Adamopoulos S, Beakle CM, McNeill JG, Pool-Wilson PA: 17β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not in men with coronary heart disease. Circulation 92: 24–30, 1995

    Google Scholar 

  34. Huanh A, Sun D, Koller A, Kaley G: Gender differences in myogenic tone of rat arterioles is due to estrogen-induced, enhanced release of NO. Am J Physiol 272: H1804–H1809, 1997

    Google Scholar 

  35. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci 93: 5925–5930, 1996

    Google Scholar 

  36. Mosselman S, Polman J, Dijkema R: ERβ: Identification and characterization of a novel human estrogen receptor. FEBS Lett 392: 49–53, 1996

    Google Scholar 

  37. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V: Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β. Mol Endocrinol 11: 353–365, 1997

    Google Scholar 

  38. Kuiper GGJM, Carlson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J-A: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138: 863–870, 1997

    Google Scholar 

  39. Thenot S, Bonnet S, Boulahtouf A, Margeat E, Royer CA, Borgna JL, Cavailles V: Effect of ligand and DNA-binding on the interaction between human transcription intermediary factor 1 alpha and estrogen receptors. Mol Endocrinol 12: 2137–2150, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Griffin, M., Lee, HW., Zhao, L. et al. Gender-related differences in proliferative response of cardiac fibroblasts to hypoxia. Mol Cell Biochem 215, 21–30 (2000). https://doi.org/10.1023/A:1026585420021

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026585420021

Navigation